VJOncology is committed to improving our service to you

ESMO Breast 2020 | MONARCH: Chemo-free options for triple-positive metastatic breast cancer

VJOncology is committed to improving our service to you

Evandro de Azambuja

Evandro de Azambuja, MD, PhD, of the Institut Jules Bordet, Brussels, Belgium, discusses how data from the MONARCH study (NCT02107703) is introducing chemotherapy-free treatment for patients with triple-positive metastatic breast cancer. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter